Every recall we track for RemedyRePack Inc. — 61 in all — plus the complaints and injury reports the public filed about them.
RemedyRePack recalls 30-count Clindamycin HCl 300mg capsules (NDC 70518-3772-02) manufactured in a shared facility with Ezetimibe tablets. This recall addresses potential contamination risks from shared equipment.
RemedyRepack Inc. recalls 300 mg Clindamycin HCl capsules due to CGMP deviations. Affected lots expire by Dec 2025. Consumers should contact the company for details.
RemedyRepack recalls Carvedilol 25mg tablets due to unsafe N-Nitroso Carvedilol Impurity-1 levels. Affected lots expire May 2025 and July 2025. Stop using immediately if you have these specific lots.
RemedyRepack recalls 100mg Phenazopyridine tablets that were mistakenly repackaged with Phenobarbital. This mix-up could cause serious harm if taken by mistake.
RemedyRepack recalls LORazepam 2mg/mL injection vials due to quality program discontinuation. Affected lots expire 2023-2025. Contact for remedy details.
RemedyRepack Inc. recalls Ketotifen Fumarate 0.025% eye drops due to quality program discontinuation. Affected units may not meet safety standards. Consumers should check NDC and lot numbers for recall.
RemedyRepack Inc. recalls 0.5mg Ropinirole tablets due to cGMP deviations in repackaging. Affected lots expire by July 2023. Consumers should check NDC and lot numbers.
RemedyRepack recalls Rosuvastatin 10mg tablets with specific NDC codes due to cGMP deviations. These prescription-only drugs may have manufacturing issues affecting safety.
RemedyRepack recalls 30-count Aripiprazole 5mg tablets (Rx only) due to cGMP deviations. Affected lots: J0620431-052322, expiring 05/31/2023.
RemedyRepack Inc. recalls 5mg Rosuvastatin tablets due to cGMP deviations. Affected lots expire by 12/31/2023. Consumers should check product labels for specific lot numbers.
RemedyRepack Inc. recalls Doxazosin 2mg tablets (NDC 70518-1560-00/01) due to cGMP deviations. Affected lots expire by 12/31/2023 or 05/31/2024. Consumers should check their bottle labels for specific lot numbers.
RemedyRepack Inc. recalls 30-count Rosuvastatin 5mg tablets (Rx only) due to cGMP deviations. Affected lots expire by Dec 2023. Consumers should check labels for specific lot numbers.
RemedyRepack Inc. recalls Rosuvastatin 40mg tablets (45-count and 90-count bottles) due to cGMP deviations. Affected lots expire 07/31/2025. Consumers should contact the manufacturer for details.
RemedyRepack recalls Atorvastatin 20mg tablets (30-count and 90-count bottles) due to cGMP deviations. These prescription drugs may have quality issues from manufacturing.
RemedyRepack Inc. recalls 30-count Tadalafil 5mg tablets (Rx only) due to cigarette packaging issues. This may cause serious injury if misused. Check your product details to see if you're affected.
RemedyRepack recalls Glimepiride 2mg tablets with specific NDC codes due to cGMP deviations. These tablets may not meet quality standards and should be checked for lot numbers.
RemedyRepack recalls Atorvastatin 10mg tablets with specific NDC codes due to cGMP deviations. Affected products may contain unsafe levels of impurities.
RemedyRepack Inc. recalls Simvastatin 40mg tablets due to cGMP deviations in manufacturing. Affected lots have specific expiration dates and NDC codes. Consumers should check their bottles for the listed lot numbers and expiration dates.
RemedyRepack Inc. recalls 180-count Ropinirole 2mg tablets (NDC 70518-2750-00) due to cGMP deviations. This medication is prescription-only and may be unsafe if improperly handled.
RemedyRepack Inc. recalls Simvastatin 10mg tablets with specific NDC codes due to cGMP deviations. These prescription-only medications may have quality issues affecting safety.
RemedyRepack Inc. recalls 300 mg Rifampin Capsules due to failed impurities and degradation specifications. This Rx-only medication may pose risks if not used properly.
RemedyRepack recalls 0.2 mg Desmopressin tablets due to subpotency. Affected products have specific NDC numbers and expiration dates. Consumers should contact the manufacturer for details.
RemedyRepack recalls 10mg Lisinopril tablets with a metal piece in one tablet. Stop using if you have the specific lot numbers listed. No remedy provided in official notice.
RemedyRePack recalls Losartan HCTZ 50/12.5mg 90-count bottles with AZIDO impurities above safe levels. Affected lots expire 10/31/2022. Stop using immediately.
RemedyRePack recalls Losartan HCTZ 100/12.5 mg 90-count bottles with AZIDO impurities above safe levels. Consumers should check NDC numbers and lot dates for affected batches.
RemedyRePack recalls Losartan HCTZ 100/25 mg tablets due to AZIDO impurity levels above safety limits. Affected lots expired by 10/31/2022.
RemedyRePack recalls Losartan Potassium 50mg tablets with AZIDO impurities above safety limits. Stop using if you have these specific blister packs.
RemedyRePack recalls Metformin 750mg Extended Release tablets with NDMA levels above safe limits. Consumers should check product lot numbers and contact the company for a replacement.
RemedyRePack recalls Cefixime 400mg capsules with failed impurities/degradation specs. Rx-only products from specific lots and NDCs may pose safety risks.
RemedyRepack Inc. recalls 180-count Carvedilol 25mg bottles (Rx only) that accidentally contain Paroxetine tablets due to repackaging error. This could cause unintended medication interactions.
